This company seems to have been delisted
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Heska Corporation
HSKA
₹10,449
Share price
0.00%
Change (1 day)
34.98%
Change (1 year)
Categories
Heska Corporation (HSKA) - Net assets
Net assets on the balance sheet as of March 2023 : ₹36.37 Billion
According to Heska Corporation
's latest financial reports the company has ₹36.37 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Heska Corporation - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $₹34.93 B | 7.7% |
| 2021-12-31 | $₹32.44 B | 54.53% |
| 2020-12-31 | $₹20.99 B | 90.71% |
| 2019-12-31 | $₹11.00 B | 28.61% |
| 2018-12-31 | $₹8.55 B | 33.46% |
| 2017-12-31 | $₹6.41 B | 8.51% |
| 2016-12-31 | $₹5.91 B | 40% |
| 2015-12-31 | $₹4.22 B | 25.37% |
| 2014-12-31 | $₹3.36 B | 15.69% |
| 2013-12-31 | $₹2.91 B | 8.8% |
| 2012-12-31 | $₹2.67 B | 4.41% |
| 2011-12-31 | $₹2.56 B | 24.86% |
| 2010-12-31 | $₹2.05 B | -1.83% |
| 2009-12-31 | $₹2.09 B | 2.28% |
| 2008-12-31 | $₹2.04 B | 21.45% |
| 2007-12-31 | $₹1.68 B | 463.1% |
| 2006-12-31 | $₹0.29 B | 105.43% |
| 2005-12-31 | $₹0.14 B | 30.26% |
| 2004-12-31 | $₹0.11 B | -63.14% |
| 2003-12-31 | $₹0.30 B | -31.38% |
| 2002-12-31 | $₹0.44 B | -46.68% |
| 2001-12-31 | $₹0.82 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 IDEXX Laboratories IDXX | ₹126.09 B | 246.69% | 🇺🇸 USA |
 Eli Lilly LLY | ₹1.379 T | 3,694.09% | 🇺🇸 USA |
 Petco WOOF | ₹96.42 B | 165.12% | 🇺🇸 USA |
 Pfizer PFE | ₹7.892 T | 21,600.57% | 🇺🇸 USA |
 Merck MRK | ₹4.214 T | 11,488.07% | 🇺🇸 USA |
 Novartis NVS | ₹3.348 T | 9,106.29% | 🇨🇭 Switzerland |
 Zoetis ZTS | ₹405.35 B | 1,014.51% | 🇺🇸 USA |